stars 1 stars 2 stars 3

AbCheck discovers and optimizes human therapeutic antibodies with one of the industry’s most versatile technology platforms. Tailored to specific needs and desired Target Product Profiles, AbCheck leverages both cutting-edge (e.g., microfluidics, rabbit mass humanization) and state-of-the-art (e.g., phage/yeast display libraries) technologies to provide high quality leads. The company has proven its capabilities in multiple partnerships throughout the U.S. and Europe. AbCheck is a wholly-owned subsidiary of Ampersand Biomedicines, a Flagship Pioneering Company.

AbCheck s.r.o. Questions

The AbCheck s.r.o. annual revenue was $2 million in 2026.

Volker Lang is the Managing Director of AbCheck s.r.o..

20 people are employed at AbCheck s.r.o..

AbCheck s.r.o. is based in Pilsen, Plzensky.

The NAICS codes for AbCheck s.r.o. are [54171, 5417, 54, 541, 541714].

The SIC codes for AbCheck s.r.o. are [87, 873].

Top AbCheck s.r.o. Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users